OQROSign up free
Insider trade

Eli Lilly (LLY): Officer sold ~$7.01M

Anat Hakim, Officer at Eli Lilly, sold ~$7.01M of Eli Lilly shares.

~$7.01M
Approx. value · 5,000 sh @ $1,402.52
4,137.46
Holds after · shares reported
Traded
Nov 2, 2026
Filed
Nov 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 18, 2026FDAFDA drug approval: Inluriyo
  2. Sep 18, 2026FDAFDA drug approval: Verzenio
  3. Sep 23, 2026FDAFDA drug approval: Onswik
  4. Sep 25, 2026FDAFDA drug approval: Olumiant
  5. Oct 9, 2026FDAFDA drug approval: Olumiant
  6. Oct 19, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.6%
  7. Oct 20, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  8. Oct 29, 2026Company filing · Form 8-K · ResultsReported its results
  9. Nov 2, 2026 · this disclosureInsiderOfficer sold ~$7.01M of LLY shares in the open market

What came next

  1. Nov 3, 2026Congress · 1 personMembers of Congress: 2 sales
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Anat Hakim, EVP, GC & Secretary

The full history of Anat Hakim, EVP, GC & Secretary is on the profile page.

How this filing works

Explore the data

Other disclosures at Eli Lilly

Everything OQRO holds on this company is on its LLY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data